LY6E and heart disorder: Currently a therapeutic Chagas vaccine is under development by a consortium of Mexican (including the Carlos Slim Health Institute) and Texan scientific institutions; based on the evidence of therapeutic efficacy of Tc24 and TSA-1 vaccines in reducing T. cruzi-induced cardiac disease in mice and dogs, the authors are pursuing Tc24 and TSA-1 as lead candidate antigens.